Single Cell Proteomics Online Symposium 202323 May 2023 | BST (UTC+1)

A comprehensive 1-day meeting that will discuss the most recent technological advancements & applications of single cell proteomics.  

From new and exciting case studies to the latest in products & services, our online event will bring together leading academics for a day of discussion, knowledge sharing and focused networking sessions. 

Download Agenda
Full details on the symposium, including the presentations, topic areas and confirmed speakers can be found in the conference brochure
Book Online
Registration for Single Cell Proteomics Symposium is now open. Please click the button below to register for this event.
LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts interested in the latest tools and strategies

Programme

The Single Cell Proteomics Online Symposium 2023 includes...

  • Hear from and meet with the key innovators in the single cell proteomics field
  • Discuss the latest innovations & developments in single cell proteomic technologies. From advancements in using microfluidics through to mass spec as well as overcoming the challenges of sample preparation with advanced technologies 
  • Discover the novel application areas of single cell proteomics. Discuss the latest advancements in various disease areas where proteomics is applied to such as oncology, cardiovascular diseases 
  • Our focused Single Cell Proteomics symposium brings together proteomic experts in a virtual format for a day of cutting-edge presentations and interactive sessions  
  • A high-quality programme devised with the help of our esteemed advisory board.  Interact with speakers during the live Q&As and explore key areas of SCP research: from mass spectrometry and labelling approaches to drug development and protein mapping 

Agenda at a Glance

Analysis, Techniques & Advanced Technologies:  

  • Advances in proteomics technologies: 
       »
    Microfluidics
       »
    Mass spectrometry
       »
    Label free approaches 
  • Multiplexing high-throughput proteomics analysis 
  • Development of antibody labels 
  • Overcoming the challenges of sample preparation in the single cell level  
  • Latest techniques in identifying novel expression profiles 
  • Proteomics data analysis at the single cell level  

Case Studies & Novel Applications:  

  • Disease areas: 
       »
    Oncology
       »
    Cardiovascular
       »
    Immunology 

 

 

Confirmed Speakers

The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future

Below are the key speakers of Single Cell Proteomics Online Symposium 2023 

David Goodlett

David Goodlett

University of Victoria

Si Wu

Si Wu

University of Oklahoma 

Kieran Campbell

Kieran Campbell

University of Toronto

Ahmet Coskun

Ahmet Coskun

Georgia Institute of Technology

Chris Rose

Chris Rose

Genentech

Markku Varjosalo

Markku Varjosalo

University of Helsinki

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in Q & A sessions and discussion panels to make the most of participation in a range of virtual, remote experiences.

Virtual Presentations
& Live Q&As

Benefit from the insight of our expert speakers via live and pre-recorded presentations. Interact with fellow attendees and speakers during regular live Q&As

Digital Networking Opportunities

Connect directly with other registrants of event around the world through the robust networking tools of our online event platform

Media Partnerships

Work, research and current challenges shared by membership associations, clusters, industry researchers, and innovation networks

WuXi AppTec.

Headline Sponsor

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,850 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”

AB Sciex LLC

Event Sponsor

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. Today, as part of the Danaher family of global life science and technology innovators, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis.

SCIEX helps scientists in biopharma discovery, development and manufacturing to transform pipeline capacity and capability through the adoption of CE and LC-MS technologies. You benefit from innovative technology that makes complex workflows easier and more efficient, while delivering the utmost in data quality. Highly reliable instrumentation, with high sensitivity and dynamic range for a variety of analytical applications. Advanced software with automation to make data processing easier.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Waters Corporation

Event Sponsor

Development, manufacturing, and quality control of oligonucleotide therapeutics require highly selective and sensitive analytical methods. This will allow increase confidence and efficiency in the development, better productivity, and ultimately faster time to market for oligonucleotides drugs. Waters provides and supports integrated compliant-ready solutions by combining purposeful innovations in liquid chromatography, mass spectrometry, and informatics.